nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2D6—Temsirolimus—kidney cancer	0.0688	0.0991	CbGbCtD
Methimazole—CYP3A4—Everolimus—kidney cancer	0.0648	0.0933	CbGbCtD
Methimazole—CYP1A2—Pazopanib—kidney cancer	0.0439	0.0632	CbGbCtD
Methimazole—CYP3A4—Temsirolimus—kidney cancer	0.0437	0.063	CbGbCtD
Methimazole—CYP2B6—Sorafenib—kidney cancer	0.0434	0.0625	CbGbCtD
Methimazole—CYP2C9—Capecitabine—kidney cancer	0.0412	0.0594	CbGbCtD
Methimazole—CYP2D6—Pazopanib—kidney cancer	0.0361	0.0521	CbGbCtD
Methimazole—CYP1A2—Erlotinib—kidney cancer	0.0313	0.0451	CbGbCtD
Methimazole—CYP2C19—Sorafenib—kidney cancer	0.0276	0.0397	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—kidney cancer	0.0263	0.0379	CbGbCtD
Methimazole—CYP2C9—Paclitaxel—kidney cancer	0.0258	0.0372	CbGbCtD
Methimazole—CYP2D6—Erlotinib—kidney cancer	0.0258	0.0371	CbGbCtD
Methimazole—CYP1A2—Sorafenib—kidney cancer	0.0254	0.0367	CbGbCtD
Methimazole—CYP3A4—Pazopanib—kidney cancer	0.023	0.0331	CbGbCtD
Methimazole—CYP2C9—Sorafenib—kidney cancer	0.0229	0.033	CbGbCtD
Methimazole—CYP2D6—Sorafenib—kidney cancer	0.021	0.0302	CbGbCtD
Methimazole—CYP2D6—Vinblastine—kidney cancer	0.0207	0.0298	CbGbCtD
Methimazole—CYP3A4—Erlotinib—kidney cancer	0.0164	0.0236	CbGbCtD
Methimazole—CYP3A4—Paclitaxel—kidney cancer	0.015	0.0216	CbGbCtD
Methimazole—CYP3A4—Sorafenib—kidney cancer	0.0133	0.0192	CbGbCtD
Methimazole—CYP3A4—Vinblastine—kidney cancer	0.0132	0.019	CbGbCtD
Methimazole—CYP3A4—Vincristine—kidney cancer	0.0129	0.0186	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—kidney cancer	0.0127	0.0183	CbGbCtD
Methimazole—CYP3A4—Sunitinib—kidney cancer	0.0108	0.0156	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—kidney cancer	0.00809	0.0117	CbGbCtD
Methimazole—Nephritis—Erlotinib—kidney cancer	0.00623	0.0354	CcSEcCtD
Methimazole—Pigmentation disorder—Sunitinib—kidney cancer	0.00552	0.0313	CcSEcCtD
Methimazole—CYP2C19—urine—kidney cancer	0.00397	0.148	CbGeAlD
Methimazole—Pigmentation disorder—Paclitaxel—kidney cancer	0.00371	0.021	CcSEcCtD
Methimazole—Ageusia—Temsirolimus—kidney cancer	0.00366	0.0208	CcSEcCtD
Methimazole—Ageusia—Pazopanib—kidney cancer	0.00345	0.0196	CcSEcCtD
Methimazole—CYP1A2—urine—kidney cancer	0.00324	0.121	CbGeAlD
Methimazole—CYP2C9—urine—kidney cancer	0.00308	0.115	CbGeAlD
Methimazole—Pigmentation disorder—Capecitabine—kidney cancer	0.00304	0.0173	CcSEcCtD
Methimazole—Neuritis—Vinblastine—kidney cancer	0.00297	0.0168	CcSEcCtD
Methimazole—CYP2E1—urine—kidney cancer	0.00292	0.109	CbGeAlD
Methimazole—Ageusia—Everolimus—kidney cancer	0.00272	0.0155	CcSEcCtD
Methimazole—CYP3A4—urine—kidney cancer	0.00235	0.0876	CbGeAlD
Methimazole—CYP2D6—urine—kidney cancer	0.00231	0.0863	CbGeAlD
Methimazole—Ageusia—Sunitinib—kidney cancer	0.00228	0.0129	CcSEcCtD
Methimazole—Neuritis—Vincristine—kidney cancer	0.00209	0.0118	CcSEcCtD
Methimazole—Neuritis—Gemcitabine—kidney cancer	0.00198	0.0112	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—kidney cancer	0.00196	0.0111	CcSEcCtD
Methimazole—Lymphadenopathy—Everolimus—kidney cancer	0.00188	0.0107	CcSEcCtD
Methimazole—Neuritis—Paclitaxel—kidney cancer	0.00166	0.00941	CcSEcCtD
Methimazole—Aplastic anaemia—Dactinomycin—kidney cancer	0.00164	0.00929	CcSEcCtD
Methimazole—Jaundice—Pazopanib—kidney cancer	0.00152	0.00865	CcSEcCtD
Methimazole—Ageusia—Capecitabine—kidney cancer	0.00125	0.00712	CcSEcCtD
Methimazole—Alopecia—Pazopanib—kidney cancer	0.00124	0.00704	CcSEcCtD
Methimazole—Neuropathy peripheral—Vinblastine—kidney cancer	0.00121	0.00689	CcSEcCtD
Methimazole—Jaundice—Everolimus—kidney cancer	0.0012	0.00683	CcSEcCtD
Methimazole—Neuropathy peripheral—Erlotinib—kidney cancer	0.00117	0.00662	CcSEcCtD
Methimazole—Leukopenia—Temsirolimus—kidney cancer	0.00116	0.00659	CcSEcCtD
Methimazole—Agranulocytosis—Vinblastine—kidney cancer	0.00116	0.00656	CcSEcCtD
Methimazole—Hepatitis—Everolimus—kidney cancer	0.00111	0.00629	CcSEcCtD
Methimazole—Myalgia—Temsirolimus—kidney cancer	0.0011	0.00626	CcSEcCtD
Methimazole—Arthralgia—Temsirolimus—kidney cancer	0.0011	0.00626	CcSEcCtD
Methimazole—Leukopenia—Pazopanib—kidney cancer	0.00109	0.0062	CcSEcCtD
Methimazole—Hepatitis—Erlotinib—kidney cancer	0.00107	0.00607	CcSEcCtD
Methimazole—Oedema—Temsirolimus—kidney cancer	0.00106	0.006	CcSEcCtD
Methimazole—Neuropathy peripheral—Sorafenib—kidney cancer	0.00105	0.00596	CcSEcCtD
Methimazole—Jaundice—Sorafenib—kidney cancer	0.00104	0.00593	CcSEcCtD
Methimazole—Arthralgia—Pazopanib—kidney cancer	0.00104	0.0059	CcSEcCtD
Methimazole—Myalgia—Pazopanib—kidney cancer	0.00104	0.0059	CcSEcCtD
Methimazole—Thrombocytopenia—Temsirolimus—kidney cancer	0.00104	0.00588	CcSEcCtD
Methimazole—Neuropathy peripheral—Sunitinib—kidney cancer	0.00101	0.00573	CcSEcCtD
Methimazole—Oedema—Pazopanib—kidney cancer	0.000997	0.00566	CcSEcCtD
Methimazole—Alopecia—Vinblastine—kidney cancer	0.000983	0.00558	CcSEcCtD
Methimazole—Alopecia—Everolimus—kidney cancer	0.000979	0.00556	CcSEcCtD
Methimazole—Thrombocytopenia—Pazopanib—kidney cancer	0.000976	0.00554	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.000964	0.00547	CcSEcCtD
Methimazole—Alopecia—Erlotinib—kidney cancer	0.000945	0.00536	CcSEcCtD
Methimazole—Somnolence—Temsirolimus—kidney cancer	0.000941	0.00534	CcSEcCtD
Methimazole—Hepatitis—Sunitinib—kidney cancer	0.000926	0.00525	CcSEcCtD
Methimazole—Agranulocytosis—Dactinomycin—kidney cancer	0.000911	0.00517	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.000908	0.00515	CcSEcCtD
Methimazole—Paraesthesia—Pazopanib—kidney cancer	0.000895	0.00508	CcSEcCtD
Methimazole—Somnolence—Pazopanib—kidney cancer	0.000886	0.00503	CcSEcCtD
Methimazole—Dyspepsia—Pazopanib—kidney cancer	0.000878	0.00498	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—kidney cancer	0.000877	0.00498	CcSEcCtD
Methimazole—Hepatitis—Dactinomycin—kidney cancer	0.000876	0.00497	CcSEcCtD
Methimazole—Vertigo—Vinblastine—kidney cancer	0.00087	0.00494	CcSEcCtD
Methimazole—Leukopenia—Vinblastine—kidney cancer	0.000867	0.00492	CcSEcCtD
Methimazole—Leukopenia—Everolimus—kidney cancer	0.000863	0.0049	CcSEcCtD
Methimazole—Neuropathy peripheral—Vincristine—kidney cancer	0.000855	0.00485	CcSEcCtD
Methimazole—Alopecia—Sorafenib—kidney cancer	0.00085	0.00482	CcSEcCtD
Methimazole—CYP2B6—nephron tubule—kidney cancer	0.000837	0.0312	CbGeAlD
Methimazole—Body temperature increased—Temsirolimus—kidney cancer	0.000837	0.00475	CcSEcCtD
Methimazole—Myalgia—Everolimus—kidney cancer	0.000821	0.00466	CcSEcCtD
Methimazole—Arthralgia—Everolimus—kidney cancer	0.000821	0.00466	CcSEcCtD
Methimazole—Alopecia—Sunitinib—kidney cancer	0.000818	0.00464	CcSEcCtD
Methimazole—Neuropathy peripheral—Gemcitabine—kidney cancer	0.000811	0.0046	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—kidney cancer	0.000808	0.00459	CcSEcCtD
Methimazole—CYP1A2—renal system—kidney cancer	0.000794	0.0296	CbGeAlD
Methimazole—Arthralgia—Erlotinib—kidney cancer	0.000792	0.0045	CcSEcCtD
Methimazole—Myalgia—Erlotinib—kidney cancer	0.000792	0.0045	CcSEcCtD
Methimazole—Oedema—Everolimus—kidney cancer	0.000787	0.00447	CcSEcCtD
Methimazole—CYP2E1—nephron tubule—kidney cancer	0.000785	0.0293	CbGeAlD
Methimazole—Alopecia—Dactinomycin—kidney cancer	0.000774	0.00439	CcSEcCtD
Methimazole—Thrombocytopenia—Vinblastine—kidney cancer	0.000774	0.00439	CcSEcCtD
Methimazole—Agranulocytosis—Gemcitabine—kidney cancer	0.000772	0.00438	CcSEcCtD
Methimazole—Thrombocytopenia—Everolimus—kidney cancer	0.000771	0.00437	CcSEcCtD
Methimazole—CYP2B6—renal system—kidney cancer	0.000761	0.0284	CbGeAlD
Methimazole—Oedema—Erlotinib—kidney cancer	0.00076	0.00431	CcSEcCtD
Methimazole—Leukopenia—Sorafenib—kidney cancer	0.00075	0.00425	CcSEcCtD
Methimazole—Pruritus—Temsirolimus—kidney cancer	0.000749	0.00425	CcSEcCtD
Methimazole—Thrombocytopenia—Erlotinib—kidney cancer	0.000744	0.00422	CcSEcCtD
Methimazole—CYP2B6—kidney—kidney cancer	0.000735	0.0275	CbGeAlD
Methimazole—Leukopenia—Sunitinib—kidney cancer	0.000721	0.00409	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000717	0.00407	CcSEcCtD
Methimazole—CYP2E1—renal system—kidney cancer	0.000714	0.0267	CbGeAlD
Methimazole—Myalgia—Sorafenib—kidney cancer	0.000713	0.00404	CcSEcCtD
Methimazole—Arthralgia—Sorafenib—kidney cancer	0.000713	0.00404	CcSEcCtD
Methimazole—Paraesthesia—Vinblastine—kidney cancer	0.00071	0.00403	CcSEcCtD
Methimazole—Paraesthesia—Everolimus—kidney cancer	0.000707	0.00401	CcSEcCtD
Methimazole—Pruritus—Pazopanib—kidney cancer	0.000705	0.004	CcSEcCtD
Methimazole—Somnolence—Everolimus—kidney cancer	0.0007	0.00397	CcSEcCtD
Methimazole—Dyspepsia—Everolimus—kidney cancer	0.000693	0.00393	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000692	0.00393	CcSEcCtD
Methimazole—Alopecia—Vincristine—kidney cancer	0.000692	0.00392	CcSEcCtD
Methimazole—CYP2E1—kidney—kidney cancer	0.00069	0.0258	CbGeAlD
Methimazole—Myalgia—Sunitinib—kidney cancer	0.000686	0.00389	CcSEcCtD
Methimazole—Arthralgia—Sunitinib—kidney cancer	0.000686	0.00389	CcSEcCtD
Methimazole—Leukopenia—Dactinomycin—kidney cancer	0.000683	0.00387	CcSEcCtD
Methimazole—CYP2B6—gonad—kidney cancer	0.000682	0.0255	CbGeAlD
Methimazole—Neuropathy peripheral—Paclitaxel—kidney cancer	0.000679	0.00385	CcSEcCtD
Methimazole—Vomiting—Temsirolimus—kidney cancer	0.000673	0.00382	CcSEcCtD
Methimazole—CYP2E1—cortex of kidney—kidney cancer	0.000672	0.0251	CbGeAlD
Methimazole—Thrombocytopenia—Sorafenib—kidney cancer	0.000669	0.0038	CcSEcCtD
Methimazole—Dyspepsia—Erlotinib—kidney cancer	0.000669	0.00379	CcSEcCtD
Methimazole—Rash—Temsirolimus—kidney cancer	0.000667	0.00379	CcSEcCtD
Methimazole—Dermatitis—Temsirolimus—kidney cancer	0.000667	0.00378	CcSEcCtD
Methimazole—Headache—Temsirolimus—kidney cancer	0.000663	0.00376	CcSEcCtD
Methimazole—Oedema—Sunitinib—kidney cancer	0.000658	0.00373	CcSEcCtD
Methimazole—Alopecia—Gemcitabine—kidney cancer	0.000656	0.00372	CcSEcCtD
Methimazole—Myalgia—Dactinomycin—kidney cancer	0.000649	0.00368	CcSEcCtD
Methimazole—Thrombocytopenia—Sunitinib—kidney cancer	0.000644	0.00365	CcSEcCtD
Methimazole—Vomiting—Pazopanib—kidney cancer	0.000634	0.0036	CcSEcCtD
Methimazole—Rash—Pazopanib—kidney cancer	0.000629	0.00357	CcSEcCtD
Methimazole—Nausea—Temsirolimus—kidney cancer	0.000629	0.00357	CcSEcCtD
Methimazole—Dermatitis—Pazopanib—kidney cancer	0.000628	0.00356	CcSEcCtD
Methimazole—Headache—Pazopanib—kidney cancer	0.000625	0.00354	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000623	0.00353	CcSEcCtD
Methimazole—Oedema—Dactinomycin—kidney cancer	0.000623	0.00353	CcSEcCtD
Methimazole—Body temperature increased—Everolimus—kidney cancer	0.000622	0.00353	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—kidney cancer	0.000615	0.00349	CcSEcCtD
Methimazole—Vertigo—Vincristine—kidney cancer	0.000612	0.00347	CcSEcCtD
Methimazole—Leukopenia—Vincristine—kidney cancer	0.00061	0.00346	CcSEcCtD
Methimazole—Thrombocytopenia—Dactinomycin—kidney cancer	0.00061	0.00346	CcSEcCtD
Methimazole—Dyspepsia—Sorafenib—kidney cancer	0.000602	0.00341	CcSEcCtD
Methimazole—Body temperature increased—Erlotinib—kidney cancer	0.0006	0.00341	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000599	0.0034	CcSEcCtD
Methimazole—Nausea—Pazopanib—kidney cancer	0.000592	0.00336	CcSEcCtD
Methimazole—Paraesthesia—Sunitinib—kidney cancer	0.00059	0.00335	CcSEcCtD
Methimazole—Myalgia—Vincristine—kidney cancer	0.00058	0.00329	CcSEcCtD
Methimazole—Dyspepsia—Sunitinib—kidney cancer	0.000579	0.00328	CcSEcCtD
Methimazole—Leukopenia—Gemcitabine—kidney cancer	0.000579	0.00328	CcSEcCtD
Methimazole—CYP3A4—renal system—kidney cancer	0.000574	0.0214	CbGeAlD
Methimazole—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000567	0.00322	CcSEcCtD
Methimazole—CYP2D6—renal system—kidney cancer	0.000565	0.0211	CbGeAlD
Methimazole—Lymphadenopathy—Doxorubicin—kidney cancer	0.000557	0.00316	CcSEcCtD
Methimazole—Neuropathy peripheral—Capecitabine—kidney cancer	0.000557	0.00316	CcSEcCtD
Methimazole—Pruritus—Everolimus—kidney cancer	0.000557	0.00316	CcSEcCtD
Methimazole—Oedema—Vincristine—kidney cancer	0.000556	0.00316	CcSEcCtD
Methimazole—CYP3A4—kidney—kidney cancer	0.000555	0.0207	CbGeAlD
Methimazole—Jaundice—Capecitabine—kidney cancer	0.000554	0.00314	CcSEcCtD
Methimazole—Myalgia—Gemcitabine—kidney cancer	0.00055	0.00312	CcSEcCtD
Methimazole—Arthralgia—Gemcitabine—kidney cancer	0.00055	0.00312	CcSEcCtD
Methimazole—Alopecia—Paclitaxel—kidney cancer	0.000549	0.00312	CcSEcCtD
Methimazole—CYP2D6—kidney—kidney cancer	0.000546	0.0204	CbGeAlD
Methimazole—Thrombocytopenia—Vincristine—kidney cancer	0.000545	0.00309	CcSEcCtD
Methimazole—Urticaria—Sorafenib—kidney cancer	0.000543	0.00308	CcSEcCtD
Methimazole—Body temperature increased—Sorafenib—kidney cancer	0.00054	0.00306	CcSEcCtD
Methimazole—Pruritus—Erlotinib—kidney cancer	0.000537	0.00305	CcSEcCtD
Methimazole—Agranulocytosis—Capecitabine—kidney cancer	0.00053	0.00301	CcSEcCtD
Methimazole—Oedema—Gemcitabine—kidney cancer	0.000528	0.00299	CcSEcCtD
Methimazole—Body temperature increased—Sunitinib—kidney cancer	0.00052	0.00295	CcSEcCtD
Methimazole—Thrombocytopenia—Gemcitabine—kidney cancer	0.000517	0.00293	CcSEcCtD
Methimazole—Hepatitis—Capecitabine—kidney cancer	0.00051	0.00289	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000507	0.00287	CcSEcCtD
Methimazole—Vomiting—Vinblastine—kidney cancer	0.000502	0.00285	CcSEcCtD
Methimazole—Vomiting—Everolimus—kidney cancer	0.000501	0.00284	CcSEcCtD
Methimazole—Paraesthesia—Vincristine—kidney cancer	0.000499	0.00283	CcSEcCtD
Methimazole—Rash—Everolimus—kidney cancer	0.000496	0.00282	CcSEcCtD
Methimazole—Dermatitis—Everolimus—kidney cancer	0.000496	0.00281	CcSEcCtD
Methimazole—Headache—Vinblastine—kidney cancer	0.000495	0.00281	CcSEcCtD
Methimazole—Headache—Everolimus—kidney cancer	0.000493	0.0028	CcSEcCtD
Methimazole—Body temperature increased—Dactinomycin—kidney cancer	0.000492	0.00279	CcSEcCtD
Methimazole—Vertigo—Paclitaxel—kidney cancer	0.000486	0.00276	CcSEcCtD
Methimazole—Leukopenia—Paclitaxel—kidney cancer	0.000485	0.00275	CcSEcCtD
Methimazole—Pruritus—Sorafenib—kidney cancer	0.000483	0.00274	CcSEcCtD
Methimazole—Vomiting—Erlotinib—kidney cancer	0.000483	0.00274	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000481	0.00273	CcSEcCtD
Methimazole—Rash—Erlotinib—kidney cancer	0.000479	0.00272	CcSEcCtD
Methimazole—Dermatitis—Erlotinib—kidney cancer	0.000479	0.00271	CcSEcCtD
Methimazole—Headache—Erlotinib—kidney cancer	0.000476	0.0027	CcSEcCtD
Methimazole—Paraesthesia—Gemcitabine—kidney cancer	0.000474	0.00269	CcSEcCtD
Methimazole—Nausea—Vinblastine—kidney cancer	0.000469	0.00266	CcSEcCtD
Methimazole—Somnolence—Gemcitabine—kidney cancer	0.000469	0.00266	CcSEcCtD
Methimazole—Nausea—Everolimus—kidney cancer	0.000468	0.00265	CcSEcCtD
Methimazole—Pruritus—Sunitinib—kidney cancer	0.000465	0.00264	CcSEcCtD
Methimazole—Myalgia—Paclitaxel—kidney cancer	0.000461	0.00261	CcSEcCtD
Methimazole—Arthralgia—Paclitaxel—kidney cancer	0.000461	0.00261	CcSEcCtD
Methimazole—Nausea—Erlotinib—kidney cancer	0.000451	0.00256	CcSEcCtD
Methimazole—Alopecia—Capecitabine—kidney cancer	0.000451	0.00256	CcSEcCtD
Methimazole—Oedema—Paclitaxel—kidney cancer	0.000442	0.00251	CcSEcCtD
Methimazole—Body temperature increased—Vincristine—kidney cancer	0.00044	0.00249	CcSEcCtD
Methimazole—Vomiting—Sorafenib—kidney cancer	0.000435	0.00247	CcSEcCtD
Methimazole—Thrombocytopenia—Paclitaxel—kidney cancer	0.000433	0.00245	CcSEcCtD
Methimazole—Rash—Sorafenib—kidney cancer	0.000431	0.00244	CcSEcCtD
Methimazole—Dermatitis—Sorafenib—kidney cancer	0.00043	0.00244	CcSEcCtD
Methimazole—Headache—Sorafenib—kidney cancer	0.000428	0.00243	CcSEcCtD
Methimazole—Vomiting—Sunitinib—kidney cancer	0.000418	0.00237	CcSEcCtD
Methimazole—Body temperature increased—Gemcitabine—kidney cancer	0.000417	0.00237	CcSEcCtD
Methimazole—Rash—Sunitinib—kidney cancer	0.000415	0.00235	CcSEcCtD
Methimazole—Dermatitis—Sunitinib—kidney cancer	0.000414	0.00235	CcSEcCtD
Methimazole—Headache—Sunitinib—kidney cancer	0.000412	0.00234	CcSEcCtD
Methimazole—Nausea—Sorafenib—kidney cancer	0.000406	0.0023	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000402	0.00228	CcSEcCtD
Methimazole—Vertigo—Capecitabine—kidney cancer	0.000399	0.00226	CcSEcCtD
Methimazole—Leukopenia—Capecitabine—kidney cancer	0.000398	0.00226	CcSEcCtD
Methimazole—Paraesthesia—Paclitaxel—kidney cancer	0.000397	0.00225	CcSEcCtD
Methimazole—Vomiting—Dactinomycin—kidney cancer	0.000396	0.00225	CcSEcCtD
Methimazole—Somnolence—Paclitaxel—kidney cancer	0.000393	0.00223	CcSEcCtD
Methimazole—Rash—Dactinomycin—kidney cancer	0.000393	0.00223	CcSEcCtD
Methimazole—Nausea—Sunitinib—kidney cancer	0.000391	0.00222	CcSEcCtD
Methimazole—Dyspepsia—Paclitaxel—kidney cancer	0.000389	0.00221	CcSEcCtD
Methimazole—Arthralgia—Capecitabine—kidney cancer	0.000378	0.00215	CcSEcCtD
Methimazole—Myalgia—Capecitabine—kidney cancer	0.000378	0.00215	CcSEcCtD
Methimazole—Pruritus—Gemcitabine—kidney cancer	0.000373	0.00212	CcSEcCtD
Methimazole—Nausea—Dactinomycin—kidney cancer	0.00037	0.0021	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—kidney cancer	0.000366	0.00208	CcSEcCtD
Methimazole—Oedema—Capecitabine—kidney cancer	0.000363	0.00206	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000359	0.00204	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—kidney cancer	0.000357	0.00203	CcSEcCtD
Methimazole—Thrombocytopenia—Capecitabine—kidney cancer	0.000355	0.00201	CcSEcCtD
Methimazole—Vomiting—Vincristine—kidney cancer	0.000354	0.00201	CcSEcCtD
Methimazole—Urticaria—Paclitaxel—kidney cancer	0.000351	0.00199	CcSEcCtD
Methimazole—Rash—Vincristine—kidney cancer	0.000351	0.00199	CcSEcCtD
Methimazole—Dermatitis—Vincristine—kidney cancer	0.00035	0.00199	CcSEcCtD
Methimazole—Body temperature increased—Paclitaxel—kidney cancer	0.000349	0.00198	CcSEcCtD
Methimazole—Headache—Vincristine—kidney cancer	0.000348	0.00198	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—kidney cancer	0.000342	0.00194	CcSEcCtD
Methimazole—Vomiting—Gemcitabine—kidney cancer	0.000335	0.0019	CcSEcCtD
Methimazole—Rash—Gemcitabine—kidney cancer	0.000333	0.00189	CcSEcCtD
Methimazole—Dermatitis—Gemcitabine—kidney cancer	0.000332	0.00189	CcSEcCtD
Methimazole—Headache—Gemcitabine—kidney cancer	0.000331	0.00188	CcSEcCtD
Methimazole—Nausea—Vincristine—kidney cancer	0.00033	0.00187	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00033	0.00187	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—kidney cancer	0.000329	0.00187	CcSEcCtD
Methimazole—Paraesthesia—Capecitabine—kidney cancer	0.000326	0.00185	CcSEcCtD
Methimazole—Dyspepsia—Capecitabine—kidney cancer	0.000319	0.00181	CcSEcCtD
Methimazole—Nausea—Gemcitabine—kidney cancer	0.000313	0.00178	CcSEcCtD
Methimazole—Pruritus—Paclitaxel—kidney cancer	0.000313	0.00177	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—kidney cancer	0.000291	0.00165	CcSEcCtD
Methimazole—Urticaria—Capecitabine—kidney cancer	0.000288	0.00163	CcSEcCtD
Methimazole—Body temperature increased—Capecitabine—kidney cancer	0.000287	0.00163	CcSEcCtD
Methimazole—Vomiting—Paclitaxel—kidney cancer	0.000281	0.00159	CcSEcCtD
Methimazole—Rash—Paclitaxel—kidney cancer	0.000279	0.00158	CcSEcCtD
Methimazole—Dermatitis—Paclitaxel—kidney cancer	0.000278	0.00158	CcSEcCtD
Methimazole—Headache—Paclitaxel—kidney cancer	0.000277	0.00157	CcSEcCtD
Methimazole—Nausea—Paclitaxel—kidney cancer	0.000262	0.00149	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—kidney cancer	0.000257	0.00146	CcSEcCtD
Methimazole—Pruritus—Capecitabine—kidney cancer	0.000256	0.00146	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—kidney cancer	0.000256	0.00145	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—kidney cancer	0.000244	0.00138	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—kidney cancer	0.000244	0.00138	CcSEcCtD
Methimazole—Oedema—Doxorubicin—kidney cancer	0.000234	0.00133	CcSEcCtD
Methimazole—Vomiting—Capecitabine—kidney cancer	0.00023	0.00131	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—kidney cancer	0.000229	0.0013	CcSEcCtD
Methimazole—Rash—Capecitabine—kidney cancer	0.000229	0.0013	CcSEcCtD
Methimazole—Dermatitis—Capecitabine—kidney cancer	0.000228	0.0013	CcSEcCtD
Methimazole—Headache—Capecitabine—kidney cancer	0.000227	0.00129	CcSEcCtD
Methimazole—Nausea—Capecitabine—kidney cancer	0.000215	0.00122	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000213	0.00121	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—kidney cancer	0.00021	0.00119	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—kidney cancer	0.000208	0.00118	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—kidney cancer	0.000206	0.00117	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—kidney cancer	0.000186	0.00105	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—kidney cancer	0.000185	0.00105	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—kidney cancer	0.000165	0.000938	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—kidney cancer	0.000149	0.000843	CcSEcCtD
Methimazole—Rash—Doxorubicin—kidney cancer	0.000147	0.000836	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—kidney cancer	0.000147	0.000835	CcSEcCtD
Methimazole—Headache—Doxorubicin—kidney cancer	0.000146	0.000831	CcSEcCtD
Methimazole—Nausea—Doxorubicin—kidney cancer	0.000139	0.000787	CcSEcCtD
Methimazole—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.63e-05	0.000353	CbGpPWpGaD
Methimazole—TPO—Metabolism—PTEN—kidney cancer	3.62e-05	0.000352	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—LDHB—kidney cancer	3.62e-05	0.000352	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PGK1—kidney cancer	3.62e-05	0.000352	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SLC5A3—kidney cancer	3.62e-05	0.000352	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.6e-05	0.00035	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.58e-05	0.000348	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—LDHB—kidney cancer	3.55e-05	0.000345	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.53e-05	0.000343	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PDHB—kidney cancer	3.52e-05	0.000342	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—POMC—kidney cancer	3.51e-05	0.000341	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.5e-05	0.000341	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—FH—kidney cancer	3.42e-05	0.000333	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APRT—kidney cancer	3.42e-05	0.000333	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GLIPR1—kidney cancer	3.39e-05	0.000329	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPAT—kidney cancer	3.39e-05	0.000329	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.36e-05	0.000327	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPAT—kidney cancer	3.36e-05	0.000327	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.35e-05	0.000325	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.32e-05	0.000322	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CRABP1—kidney cancer	3.31e-05	0.000322	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CCBL1—kidney cancer	3.31e-05	0.000322	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.28e-05	0.000319	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GPC3—kidney cancer	3.22e-05	0.000313	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ACY1—kidney cancer	3.2e-05	0.000311	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—FH—kidney cancer	3.15e-05	0.000306	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APRT—kidney cancer	3.15e-05	0.000306	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CA9—kidney cancer	3.14e-05	0.000305	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CA2—kidney cancer	3.13e-05	0.000305	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APRT—kidney cancer	3.12e-05	0.000304	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—FH—kidney cancer	3.12e-05	0.000304	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ITPR2—kidney cancer	3.08e-05	0.000299	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CA9—kidney cancer	3.08e-05	0.000299	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALAD—kidney cancer	3.05e-05	0.000297	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.05e-05	0.000297	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.99e-05	0.000291	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.98e-05	0.00029	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GPC3—kidney cancer	2.96e-05	0.000288	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GPC3—kidney cancer	2.94e-05	0.000285	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.91e-05	0.000283	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CA2—kidney cancer	2.88e-05	0.00028	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPAT—kidney cancer	2.87e-05	0.000279	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.87e-05	0.000279	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CA2—kidney cancer	2.86e-05	0.000278	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.83e-05	0.000276	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALAD—kidney cancer	2.81e-05	0.000273	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTT1—kidney cancer	2.81e-05	0.000273	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ACHE—kidney cancer	2.81e-05	0.000273	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.81e-05	0.000273	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.79e-05	0.000271	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PGK1—kidney cancer	2.79e-05	0.000271	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALAD—kidney cancer	2.78e-05	0.000271	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.74e-05	0.000266	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—LDHB—kidney cancer	2.74e-05	0.000266	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PDHB—kidney cancer	2.72e-05	0.000264	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.72e-05	0.000264	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—POMC—kidney cancer	2.71e-05	0.000263	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.68e-05	0.00026	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CRABP1—kidney cancer	2.67e-05	0.00026	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—FH—kidney cancer	2.67e-05	0.000259	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APRT—kidney cancer	2.67e-05	0.000259	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SCARB1—kidney cancer	2.66e-05	0.000258	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.66e-05	0.000258	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS1—kidney cancer	2.63e-05	0.000256	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CRABP1—kidney cancer	2.62e-05	0.000254	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.61e-05	0.000254	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PSMD7—kidney cancer	2.58e-05	0.000251	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.57e-05	0.00025	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PGK1—kidney cancer	2.57e-05	0.00025	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CA—kidney cancer	2.56e-05	0.000248	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CCBL1—kidney cancer	2.56e-05	0.000248	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.55e-05	0.000247	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PGK1—kidney cancer	2.55e-05	0.000247	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—LDHB—kidney cancer	2.52e-05	0.000245	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GPC3—kidney cancer	2.51e-05	0.000244	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—LDHB—kidney cancer	2.5e-05	0.000243	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ITPR2—kidney cancer	2.48e-05	0.000241	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—BCHE—kidney cancer	2.45e-05	0.000238	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CA2—kidney cancer	2.44e-05	0.000237	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ITPR2—kidney cancer	2.43e-05	0.000236	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SLC5A5—kidney cancer	2.42e-05	0.000235	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALAD—kidney cancer	2.38e-05	0.000231	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CA9—kidney cancer	2.37e-05	0.000231	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SLC2A1—kidney cancer	2.33e-05	0.000227	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.32e-05	0.000226	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.32e-05	0.000226	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.27e-05	0.000221	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTT1—kidney cancer	2.26e-05	0.00022	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ACHE—kidney cancer	2.26e-05	0.00022	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTT1—kidney cancer	2.22e-05	0.000216	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ACHE—kidney cancer	2.22e-05	0.000216	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPAT—kidney cancer	2.22e-05	0.000215	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.22e-05	0.000215	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CA9—kidney cancer	2.18e-05	0.000212	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.18e-05	0.000211	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PGK1—kidney cancer	2.18e-05	0.000211	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CA9—kidney cancer	2.16e-05	0.00021	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SCARB1—kidney cancer	2.14e-05	0.000208	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—LDHB—kidney cancer	2.13e-05	0.000207	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS1—kidney cancer	2.12e-05	0.000206	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.12e-05	0.000206	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SCARB1—kidney cancer	2.1e-05	0.000204	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PSMD7—kidney cancer	2.08e-05	0.000202	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS1—kidney cancer	2.08e-05	0.000202	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APRT—kidney cancer	2.06e-05	0.0002	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—FH—kidney cancer	2.06e-05	0.0002	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PSMD7—kidney cancer	2.04e-05	0.000198	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CRABP1—kidney cancer	2.02e-05	0.000196	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—BCHE—kidney cancer	1.97e-05	0.000192	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.95e-05	0.000189	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTP1—kidney cancer	1.95e-05	0.000189	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPC3—kidney cancer	1.94e-05	0.000188	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—BCHE—kidney cancer	1.93e-05	0.000188	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.91e-05	0.000186	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CA2—kidney cancer	1.88e-05	0.000183	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.88e-05	0.000183	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ITPR2—kidney cancer	1.88e-05	0.000182	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CRABP1—kidney cancer	1.86e-05	0.00018	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CA9—kidney cancer	1.85e-05	0.00018	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.84e-05	0.000179	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ABCB1—kidney cancer	1.84e-05	0.000179	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CRABP1—kidney cancer	1.84e-05	0.000179	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALAD—kidney cancer	1.84e-05	0.000178	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.81e-05	0.000176	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.79e-05	0.000174	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTM1—kidney cancer	1.79e-05	0.000174	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.75e-05	0.00017	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.73e-05	0.000168	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ITPR2—kidney cancer	1.73e-05	0.000168	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ACHE—kidney cancer	1.71e-05	0.000166	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTT1—kidney cancer	1.71e-05	0.000166	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ITPR2—kidney cancer	1.71e-05	0.000166	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.69e-05	0.000165	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.68e-05	0.000163	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PGK1—kidney cancer	1.68e-05	0.000163	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LDHB—kidney cancer	1.65e-05	0.00016	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SCARB1—kidney cancer	1.62e-05	0.000157	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS1—kidney cancer	1.6e-05	0.000156	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.58e-05	0.000153	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTT1—kidney cancer	1.57e-05	0.000153	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ACHE—kidney cancer	1.57e-05	0.000153	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CRABP1—kidney cancer	1.57e-05	0.000153	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PSMD7—kidney cancer	1.57e-05	0.000153	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTP1—kidney cancer	1.57e-05	0.000153	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ACHE—kidney cancer	1.56e-05	0.000152	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTT1—kidney cancer	1.56e-05	0.000152	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTP1—kidney cancer	1.54e-05	0.000149	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—BCHE—kidney cancer	1.49e-05	0.000145	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SCARB1—kidney cancer	1.49e-05	0.000145	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ABCB1—kidney cancer	1.49e-05	0.000144	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SCARB1—kidney cancer	1.48e-05	0.000144	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS1—kidney cancer	1.47e-05	0.000143	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.47e-05	0.000143	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ITPR2—kidney cancer	1.46e-05	0.000142	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS1—kidney cancer	1.46e-05	0.000142	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ABCB1—kidney cancer	1.46e-05	0.000141	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PSMD7—kidney cancer	1.45e-05	0.000141	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTM1—kidney cancer	1.44e-05	0.00014	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PSMD7—kidney cancer	1.43e-05	0.000139	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CA9—kidney cancer	1.43e-05	0.000139	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.42e-05	0.000138	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTM1—kidney cancer	1.41e-05	0.000137	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.38e-05	0.000134	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—BCHE—kidney cancer	1.37e-05	0.000133	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.37e-05	0.000133	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BCHE—kidney cancer	1.36e-05	0.000132	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.35e-05	0.000132	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.35e-05	0.000131	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.34e-05	0.000131	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.34e-05	0.00013	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—kidney cancer	1.33e-05	0.00013	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ACHE—kidney cancer	1.33e-05	0.00013	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.31e-05	0.000127	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.3e-05	0.000126	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—POMC—kidney cancer	1.26e-05	0.000123	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SCARB1—kidney cancer	1.26e-05	0.000123	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.26e-05	0.000122	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS1—kidney cancer	1.25e-05	0.000121	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PSMD7—kidney cancer	1.23e-05	0.000119	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CRABP1—kidney cancer	1.21e-05	0.000118	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.2e-05	0.000117	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—kidney cancer	1.19e-05	0.000115	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BCHE—kidney cancer	1.16e-05	0.000113	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.15e-05	0.000112	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ITPR2—kidney cancer	1.13e-05	0.00011	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCB1—kidney cancer	1.12e-05	0.000109	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.11e-05	0.000108	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.1e-05	0.000107	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—kidney cancer	1.09e-05	0.000106	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—kidney cancer	1.09e-05	0.000106	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—kidney cancer	1.08e-05	0.000105	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.08e-05	0.000105	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.03e-05	0.0001	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCB1—kidney cancer	1.03e-05	0.0001	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—kidney cancer	1.03e-05	0.0001	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ACHE—kidney cancer	1.03e-05	0.0001	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCB1—kidney cancer	1.02e-05	9.95e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—POMC—kidney cancer	1.02e-05	9.91e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—kidney cancer	1.01e-05	9.8e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—kidney cancer	1e-05	9.75e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—POMC—kidney cancer	9.99e-06	9.71e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—kidney cancer	9.94e-06	9.66e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SCARB1—kidney cancer	9.74e-06	9.47e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS1—kidney cancer	9.64e-06	9.37e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A1—kidney cancer	9.5e-06	9.24e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PSMD7—kidney cancer	9.46e-06	9.19e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A1—kidney cancer	9.42e-06	9.16e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.38e-06	9.12e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—kidney cancer	9.24e-06	8.98e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BCHE—kidney cancer	8.96e-06	8.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.85e-06	8.61e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—kidney cancer	8.79e-06	8.54e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCB1—kidney cancer	8.75e-06	8.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.55e-06	8.31e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—kidney cancer	8.49e-06	8.26e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.49e-06	8.25e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—kidney cancer	8.13e-06	7.91e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1A1—kidney cancer	8.05e-06	7.83e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—kidney cancer	7.96e-06	7.74e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.74e-06	7.52e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—POMC—kidney cancer	7.7e-06	7.49e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—kidney cancer	7.13e-06	6.93e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—kidney cancer	7.09e-06	6.89e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—POMC—kidney cancer	7.09e-06	6.89e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—POMC—kidney cancer	7.02e-06	6.83e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—kidney cancer	6.95e-06	6.75e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCB1—kidney cancer	6.75e-06	6.56e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.61e-06	6.43e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—kidney cancer	6.55e-06	6.37e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.21e-06	6.04e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—kidney cancer	6.2e-06	6.03e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—kidney cancer	6.15e-06	5.97e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—POMC—kidney cancer	6e-06	5.84e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—kidney cancer	5.65e-06	5.49e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—kidney cancer	5.6e-06	5.45e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—kidney cancer	5.36e-06	5.21e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—kidney cancer	5e-06	4.86e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—kidney cancer	4.93e-06	4.79e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.9e-06	4.76e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—kidney cancer	4.89e-06	4.75e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—kidney cancer	4.79e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—POMC—kidney cancer	4.63e-06	4.5e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—kidney cancer	4.18e-06	4.06e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.78e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—kidney cancer	3.7e-06	3.59e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.48e-06	3.38e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.45e-06	3.35e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—kidney cancer	3.22e-06	3.13e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.95e-06	2.86e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.27e-06	2.21e-05	CbGpPWpGaD
